Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, vol.29, issue.Suppl, pp.1333-1375, 2013. ,
DOI : 10.1111/j.1478-3231.2008.01927.x
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies, Nature Medicine, vol.56, issue.7, pp.837-886, 2013. ,
DOI : 10.1073/pnas.0915117107
Treatment as prevention and cure towards global eradication of hepatitis C virus, Trends in Microbiology, vol.21, issue.12, pp.625-658, 2013. ,
DOI : 10.1016/j.tim.2013.09.008
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, Clin Infect Dis, vol.59, pp.2006-20121411, 2014. ,
The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease, Top Antivir Med, vol.21, pp.15-24, 2013. ,
Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men, Gastroenterology, vol.136, issue.5, pp.1609-1626, 2009. ,
DOI : 10.1053/j.gastro.2009.02.006
Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine, Hepatology, vol.8, issue.Suppl 1, pp.1303-1316, 2013. ,
DOI : 10.1016/S1473-3099(08)70126-9
URL : https://hal.archives-ouvertes.fr/inserm-00812948
Prospects for prophylactic hepatitis C vaccines based on virus-like particles, Human Vaccines & Immunotherapeutics, vol.12, issue.5, pp.1112-1120, 2013. ,
DOI : 10.1126/scitranslmed.3003155
URL : https://hal.archives-ouvertes.fr/inserm-00812949
Bioengineering virus-like particles as vaccines, Biotechnology and Bioengineering, vol.376, issue.9744, pp.425-465, 2014. ,
DOI : 10.1016/S0140-6736(10)61030-6
Hepatitis B virus infection, The Lancet, vol.384, issue.9959, pp.60220-60228, 2014. ,
DOI : 10.1016/S0140-6736(14)60220-8
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine, Vaccine, vol.21, issue.21-22, pp.2692-2699, 2003. ,
DOI : 10.1016/S0264-410X(03)00182-8
Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine, Biotechnology and Bioengineering, vol.11, issue.12, pp.2343-51, 2013. ,
DOI : 10.1016/0264-410X(93)90042-V
A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon, PLoS ONE, vol.4, issue.10, p.7611, 2009. ,
DOI : 10.1371/journal.pone.0007611.s002
Hepatitis B vaccines: WHO position paperrecommendations, Vaccine, vol.28, pp.589-90, 2010. ,
Response to Booster Doses of Hepatitis B Vaccine among Young Adults Who Had Received Neonatal Vaccination, PLoS ONE, vol.27, issue.9, p.107163, 2014. ,
DOI : 10.1371/journal.pone.0107163.g002